Sergio Mompart Barrenechea

Sergio Mompart Barrenechea

Auto-generated profile, based on publicly available information

Sergio Mompart Barrenechea

Laboratory of Epigenetics and Neuroendocrinology, Institute for Neuroscience, Department of Health Science and Technology, ETH Zürich, Zürich, Switzerland

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2020 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
ABAhmed Besheer
Ahmed Besheer
HMHanns-Christian Mahler
Hanns-Christian Mahler
AMAnja Matter-Schwald
Anja Matter-Schwald
SBSergio Mompart Barrenechea
Sergio Mompart Barrenechea
MVMartin Vogt
Martin Vogt
RMRoman Mathaes
Roman Mathaes

9 December 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
MGMahshid Gazorpak
Mahshid Gazorpak
KHKarina M. Hugentobler
Karina M. Hugentobler
DPDominique Paul
Dominique Paul
PGPierre-Luc Germain
Pierre-Luc Germain
MKMiriam Kretschmer
Miriam Kretschmer
KGKatharina Gapp
Katharina Gapp
Counteracting the overactivation of glucocorticoid receptors (GR) is an important therapeutic goal in stress-related psychiatry and beyond. The only clinically approved GR antagonist lacks selectivity and induces unwanted side effects. To complement existing tools of small-molecule-based inhibitors, we present a highly potent, catalytically-driven GR degrader, KH-103, based on proteolysis-targeting chimera technology. This selective degrader enables immediate and reversible GR depletion that is independent of genetic manipulation and circumvents transcriptional adaptations to inhibition. KH-103 achieves passive inhibition, preventing agonistic induction of gene expression, and significantly averts the GR’s genomic effects compared to two currently available inhibitors. Application in primary-neuron cultures revealed the dependency of a glucocorticoid-induced increase in spontaneous calcium activity on GR. Finally, we present a proof of concept for application in vivo. KH-103 opens opportunities for a more lucid interpretation of GR functions with translational potential.